360° tour of a proton therapy center with ProteusPLUS

Описание: This 360° virtual tour provides an in-depth look at a ProteusPLUS proton therapy center, highlighting the advanced technology and patient experience involved in this cutting-edge cancer treatment. A typical patient daily visit is showcased, including imaging, preparation, and treatment phases.

When the patient enters the treatment room, they are positioned onto the treatment couch. Advanced positioning devices ensure consistent and reproducible positioning for every treatment session. The ProteusPLUS gantry rotates 360° around the patient, allowing precise tumor targeting from any angle, and CBCT technology is used to obtain a 3D view of the body and the tumor.

In the treatment control room, therapists review acquired images to assess the patient’s position and make corrections if necessary. In-room-CT technology provides high-quality images to visualize any anatomical changes within the patient.

The treatment for head and neck cases here, start with an invisible beam that targets the tumor from three different angles to ensure fully coverage. Proton therapy allows for precise targeting of tumors and cancer cells while sparing healthy tissue, significantly reducing side effects during and after treatment. Proton therapy improves quality of life and overall treatment outcomes. The treatment lasts only a few minutes, and the patient feels nothing, with therapists monitoring the process from the control room using adaptive treatment software.

The number of patients receiving proton therapy is rising, with over a thousand treated at IBA-equipped centers. However, only 1% have access to this advanced treatment, but IBA is dedicated to making proton therapy available to all eligible patients.


Key Highlights:

(00:00) Virtual tour of a proton therapy center

(00:32) Inside the treatment room: understanding the gantry

(00:48) Patient positioning in proton therapy

(01:05) CBCT technology for 3D imaging

(01:16) Inside the treatment control room: patient monitoring and adjustments

(01:32) In-room-CT technology for high-quality images

(01:54) Proton therapy treatment: What to expect

(02:08) Benefits of proton therapy

(02:59) Essential statistics on proton therapy


CBCT: Cone Beam Computed Tomography, In-room-CT: In-room-computed tomography.



📚 Wish to gain further insights into IBA proton therapy centers? Take a closer look here: https://www.iba-protontherapy.com/iba...


#ProtonTherapy #MedicalPhysics #RadiationOncology #PrecisionRadiotherapy #MedicalDevice #ProtonTherapyCenter #VirtualTour #ProteusONE #PatientExperience #PatientCare #ConeBeamCT #InRoomCT


Tag: Proton, Cancer, Radiotherapy, Oncology, Radiation, Irradiation, CBCT, Gantry, Positioning, Patient.


Disclaimer: ProteusPLUS availability is subject to local listings. Please contact your IBA representative for product availability in your area.


--------------------Learn more ------------------------

Radiation oncology with ProteusONE| IBA Proton Therapy    • Radiation Oncology with ProteusONE | IBA P...  

How does proton therapy work?    • Видео  

360° tour of a proton therapy center with ProteusONE    • 360° tour of a proton therapy center with ...  


--------------------Follow us----------------------------

Discover us on LinkedIn:   / iba-proton-therapy  

Find us on Facebook:   / ibatoday  

Subscribe to this YouTube channel:    / @ibaprotontherapy  


-------------------- About IBA---------------------------

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance."